Dr. Philippe Vangrieken, PhD, EuCP, ERT, is Assistant Professor at Maastricht University Medical Center+ and Maastricht University, affiliated with the Departments of Internal Medicine and Pharmacology & Toxicology and CARIM. His current research focuses on the role of methylglyoxal, advanced glycation end products and glyoxalase-1 in vascular aging, endothelial dysfunction, insulin resistance, diabetes and pregnancy-related vascular complications. Using translational approaches that combine preclinical models, vascular function measurements, molecular analyses and human cohort data, his work aims to identify mechanisms, biomarkers and therapeutic targets for cardiometabolic and vascular disease. He leads an independent research line supported by competitive funding, including a Diabetes Fonds Junior Fellowship, Maastricht UMC+ Starter Grant and other research grants. He supervises PhD, Master and Bachelor students and contributes to pharmacology, toxicology and biomedical education. He is a European Certified Pharmacologist and European Registered Toxicologist, and a member of professional societies including the Dutch Society of Pharmacology, DALAS, the International Maillard Reaction Society and the European Society for Microcirculation.
Dr. Philippe Vangrieken, PhD, EuCP, ERT, is Assistant Professor at Maastricht University Medical Center+ and Maastricht University, affiliated with the Departments of Internal Medicine and Pharmacology & Toxicology and CARIM. His current research focuses on the role of methylglyoxal, advanced glycation end products and glyoxalase-1 in vascular aging, endothelial dysfunction, insulin resistance, diabetes and pregnancy-related vascular complications. Using translational approaches that combine preclinical models, vascular function measurements, molecular analyses and human cohort data, his work aims to identify mechanisms, biomarkers and therapeutic targets for cardiometabolic and vascular disease. He leads an independent research line supported by competitive funding, including a Diabetes Fonds Junior Fellowship, Maastricht UMC+ Starter Grant and other research grants. He supervises PhD, Master and Bachelor students and contributes to pharmacology, toxicology and biomedical education. He is a European Certified Pharmacologist and European Registered Toxicologist, and a member of professional societies including the Dutch Society of Pharmacology, DALAS, the International Maillard Reaction Society and the European Society for Microcirculation.